# Philippe Degive

> Philippe Degive is a Series A investor at S.R.I.W. backing Health Care and Manufacturing. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [S.R.I.W.](https://shizune.co/investors/profile/s-r-i-w)
- Total investments: 3
- Last investment: Sep 2019
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/philippe-degive-19152227

Philippe Degive is a Series A investor at S.R.I.W. focused on Health Care and Manufacturing. Philippe Degive is investment manager with Société Régionale d'Investissement de Wallonie (“S.R.I.W.”) SA. Created in 1979, the S.R.I.W. Group is an institution owned by the Walloon Government that assists entrepreneurs in creating and developing businesses in the Walloon region. Philippe is responsible for a portfolio of investments infunds and companies active in the pharmaceutical industry and biotechnology. He is also a director in a series of investee companies of S.R.I.W. Before joining S.R.I.W., Philippe headed Cedip Management SPRL, a company specialised in consulting to enterprises and corporate finance. He has been for more than 10 years a manager with Fortis Bank SA where he has held several responsible positions. He started his career with Petrofina SA.He has been involved in a wide range of transactions. He has also been a regular speaker for different organisations such as e.g. the Belgian banking association, the Liège University, the Chamber of Commerce etc ...

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 33% |
| Manufacturing | 1 | 33% |
| Medical Device | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| iSTAR Medical | iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $43.9M | Series C | Sep 05, 2019 |  |
| iSTAR Medical | iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $11M | Series B | Apr 12, 2016 |  |
| iSTAR Medical | iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.By 2012, iSTAR received ISO 13485 and ISO 9001 Quality SystemsCertifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant. | $4.4M | Series A | Nov 21, 2013 |  |

3 of 3 investments shown.

## Co-investors
- [Capricorn Partners](https://shizune.co/investors/profile/capricorn-partners) — VC Fund, 3 deals together
- [SFPI-FPIM](https://shizune.co/investors/profile/sfpi-fpim) — VC Fund, 2 deals together
- [BNP Paribas Private Equity](https://shizune.co/investors/profile/bnp-paribas-private-equity) — VC Fund, 1 deal together
- [Earlybird Venture Capital](https://shizune.co/investors/profile/earlybird-venture-capital) — VC Fund, 1 deal together
- [Gimv](https://shizune.co/investors/profile/gimv) — VC Fund, 1 deal together
- [LSP](https://shizune.co/investors/profile/lsp) — VC Fund, 1 deal together

## About S.R.I.W.

VC Fund · Liège, Belgium

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

5 contacts available at S.R.I.W..

| Name | Title | Profile |
| --- | --- | --- |
| Damien Lourtie | Chief Financial Officer | https://shizune.co/investors/profile/damien-lourtie |
| Gery Lefebvre | Investment Manager | https://shizune.co/investors/profile/gery-lefebvre |
| Jean-Pascal LABILLE | Chairman | https://shizune.co/investors/profile/jean-pascal-labille |
| Philippe Degive | Investment Manager | https://shizune.co/investors/profile/philippe-degive |
| Thibaut Claes | Investment Manager | https://shizune.co/investors/profile/thibaut-claes |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Philippe Degive invest in?

Philippe Degive invests primarily in Health Care, Manufacturing and Medical Device startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Philippe Degive last invest?

The most recent investment recorded for Philippe Degive closed in Sep 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co